Lv2
167 积分 2021-06-09 加入
Mechanisms of Disease: pathogenesis and treatment of ANCA-associated vasculitides
14小时前
已完结
ANCA-associated vasculitides—advances in pathogenesis and treatment
14小时前
已完结
Complement in ANCA-associated vasculitis: mechanisms and implications for management
19小时前
已完结
A Phase 3 Trial of Telitacicept for Systemic Lupus Erythematosus
19天前
已完结
Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis
19天前
已完结
Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis
19天前
已完结
Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial
19天前
已完结
NEPHRUTIX: A randomized, double-blind, placebo vs Rituximab-controlled trial assessing T-cell subset changes in Minimal Change Nephrotic Syndrome
19天前
已完结
Rituximab or Cyclophosphamide in the Treatment of Membranous Nephropathy: The RI-CYCLO Randomized Trial
19天前
已完结
Obinutuzumab or Tacrolimus in Primary Membranous Nephropathy
19天前
已完结
皖公网安备34019202002308
